# Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

> **NCT00483574** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 1378 (actual)

## Conditions studied

- Meningococcal Meningitis
- Measles
- Mumps
- Rubella
- Varicella

## Interventions

- **BIOLOGICAL:** Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
- **BIOLOGICAL:** Measles-mumps-rubella-varicella vaccine
- **BIOLOGICAL:** Routine paediatric vaccine - Pneumococcal conjugate (PCV)
- **BIOLOGICAL:** Routine paediatric vaccine - Hepatitis A

## Key facts

- **NCT ID:** NCT00483574
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2009-01
- **Final completion:** 2009-04
- **Target enrollment:** 1378 (ACTUAL)
- **Last updated:** 2016-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483574, "Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00483574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*